UK based MNC,Helix Research Center has announced Medical Research Services for the Global Clinical Trial Sponsors in Asian Tiger Countries of Taiwan,Hong Kong,South Korea and Singapore
Online PR News – 20-March-2011 – – It is an established truth that the Four Asian Nations;Taiwan,Hongkong,South Korea and Singapore are considered highly developed economies and are known as Tiger or Dragon Countries.Though Hongkong and Singapore have emerged as International Finance Centers and Taiwan and South Korea are well know for their expertise in Information Technology,all these four Nations are more or less similar with reference to their Medical Research promotional endeavours.Inspired by the Policies of Ministries of Health and Regulatory Authorities,initiatives taken by various Professional Organisations and Research Community to promote New Drug Discovery and Ethical Clinical Research,Helix Research Center has taken an initiative to offer Medical Research and Educational Services for the Global Biopharmaceutical,Medical Device,Cosmetic Industry,Global Voluntary Organisations promoting Research and Development/Healthcare and Research Community of these Four Asian Tiger economies respectively.
The National Health Insurance system (NHI) in Taiwan assures Healthcare to all its Citizens and the National Health Research Institutes (NHRI) which is under direct supervision of Department of Health,People's Republic of China (PRC) has been working relentlessly to promote Healthcare and Medical Research.Most of the Hospitals across Taiwan have the potential to conduct Clinical Trials in any major Therapeutic area and the enthusiastic Medical Community is known for completing the Trials within the stipulated period of time.Taiwan has a huge pool of Life Sciences Graduates,Post Graduates and a substantial number of PhDs to work as Clinical Research Associates,Clinical Research Cooridnators and other support staff.Since Taiwan has a well developed Road,Rail and Air transport system,shipping of the Clinical Trial samples of Investigational New Products can be accomplishes with ease.
Hong Kong ,which is one of the Special Administrative Region of People's Republic of China is one of the densely populated country in Asia and one of the World's leading Financial Center.The oldest Institution of Tertiary Education;the University of Hongkong and many other Universities produce prospective support staff for the Clinical Research Investigators to expedite Phase 0 to IV,Pre Clinical or Bioavailability and Bio Equivalence (BA/BE) Studies for any Global Sponsor.Highly developed and Sophisticated Public/Private transport network in Hong Kong facilitates quicker commutering by Public and also hassle free transport of Medical supplies/Clinical Trial samples.The Continual efforts of Food and Health Bureau,the Hospital Authority;Government of Hong Kong,the Hong Kong Association of the Pharmaceutical Industry (HKAPI),the Hong Kong Private Hospitals Association and various other Professional Associations to promote Healthcare,Medical Research and R&D initiatives have created congenial and highly Professional environment for conducting Global Clincal Trials.
Being the Member of OECD ( Organisation for Economic Co operation and Development) countries,South Korea has emerged as one of the preferred destinations for Global Clinical Trials.The Slogan of Ministry of Health and Welfare,Government of Korea' The People's Voice is the Voice of Heaven' and the 'Online Government Services' available for any Citizen of South Korea,the efforts of the Ministry to provide Quality Healthcare to all its Citizens is praiseworthy indeed.The efforts of Korean Food and Drug Administration (KFDA) to ensure Safety of Clinical Trial Subjects by providing necessary Guidelines for Conducting Clinical Trials is remarkable.South Korea has substantial number of Life Life Sciences aspirants,Doctors,Nurses and Scientists to expedite a Clinical Research Project under strict GCP ( Good Clinical Practices ) Compliance.The Rapid Transit Subways and other means of Transport of in South Korea are of International standard.,
Being one of the World's leading Financial Center,with diverse population,Singapore has emerged as one of leading destinations for Global Clinical Trials.The Healthcare delivery in Singapore is accomplished by Public( National Healthcare Group-NHG and Singapore Health Services-SHS) and state of the art Private Healthcare systems.Singapore is one the World's favored Medical Tourism Centers.The efforts and multipronged approach of National Medical Research Council (NMRC),established by Ministry of Health,Singapore ,inroder to promote Ethical Research,R&D endeavours etc is a Role Model for many countries indeed.The Spohisticated Road,Rail,Air Transport System in Singapore is most convenient for Clinical Supplies/Clinical Trial sample shipping.The highly qualified and Trained Doctors of various Specialties strive hard to expedite their Clinical Research Projects within Timelines.
Helix Research Center will provide entire spectrum Scientific and Therapeutic Research Services for the Global Clinical Trial Sponsors and also Short Term Clinical Research Vocational Training Courses.The promoters of Helix Research Center always keep away from 'Competition' ,'Conflict of Interest' etc and embrace 'Cooperation,Collaboration,Ergonomics' etc.Further,Helix is keen to get associated with like minded Professionals,Associations,Institutions in any part of the World,inorder to promote New Drug Discovery,Preventive and Curative Healthcare.Since there is a dire need for Interpretation of GCPs Pan World,Helix has taken an initiative to Organise Seminars and Conferences in different regions of the World .